Summary
Molbio Diagnostics shares debuted at a 21.44% premium on both BSE and NSE, listing at ₹980 against an issue price of ₹807, despite a weak overall stock market.
Molbio Diagnostics IPO Shares Debut at 21% Premium Amid Weak Market
HyperFast News
Related news
Molbio Diagnostics Share Price Falls 9%, Loses 18.5% in 2 Days After Rally
20 Sept 2026, 12:03 am · News
Molbio Diagnostics Share Price Hits 20% Upper Circuit, Jumps 87% from IPO Price
20 Sept 2026, 12:03 am · News
Molbio Diagnostics Outlines Global Expansion and Truenat Growth Plans After Successful IPO
20 Sept 2026, 12:03 am · News
